Patient Characteristics | No. |
---|---|
Patients with low-ADC lesions | 27 |
Age (median) (range) | 53 (34–74) |
Sex | |
Men | 20 |
Women | 7 |
Chemotherapy at time of low-ADC lesion | |
Contains bevacizumab | 15 |
Bevacizumab only | 7 |
Bevacizumab and irinotecan | 1 |
Bevacizumab and temozolomide | 5 |
Bevacizumab and carboplatin | 1 |
Bevacizumab and lomustine | 1 |
Does not contain bevacizumab | 6 |
Temozolomide only | 6 |
None | 6 |